GleamWall
中文EN

BDX BECTON DICKINSON & CO

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 10795 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.2%
TTM net income YoY-40.6%
TTM EPS YoY-39.5%
Revenue 3-yr CAGR3.0%
Net income 3-yr CAGR-17.3%

Margins

Gross margin46.4%
Operating margin9.6%
Net margin4.5%
FCF margin13.1%
EBITDA margin21.6%

Returns

ROE3.8%
ROA1.8%
ROIC (approx.)4.2%
Asset turnover0.39x

Leverage & solvency

Liabilities / assets51.9%
Debt / equity0.69x
Current ratio0.87x
Interest coverage3.40x

Cash quality & payout

Operating cash flow / net income3.67x
Accruals ratio-4.8%
Payout ratio124.5%
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue$21.84B$20.18B
Cost of revenue$11.91B$11.05B
Gross profit$9.93B$9.12B
R&D expense$1.26B$1.19B
SG&A expense$5.28B$4.86B
Operating income$2.58B$2.40B
Interest expense$613.00M$528.00M
Pretax income$1.88B$2.00B
Income tax$203.00M$300.00M
Net income$1.68B$1.71B
EBITDA$5.04B$4.68B
EPS (basic)5.835.88
EPS (diluted)5.825.86
Dividends declared per share4.163.80
Weighted avg. shares (diluted)288.51M291.01M
Balance sheet
Cash & equivalents$567.00M$1.79B
Receivables$2.40B$3.03B
Inventory$3.15B$3.84B
Current assets$9.26B$10.47B
PP&E, net$6.38B$6.82B
Goodwill$25.96B$26.46B
Intangibles$9.23B$10.87B
Total assets$55.33B$57.29B
Current liabilities$8.31B$8.96B
Short-term debt$1.56B$2.17B
Long-term debt$17.62B$17.94B
Total debt$19.18B$20.11B
Total liabilities$29.93B$31.40B
Shareholders' equity$25.39B$25.89B
Net debt$18.61B$18.32B
Cash flow statement
Operating cash flow$3.43B$3.84B
Capital expenditure$760.00M$725.00M
Free cash flow$2.67B$3.12B
Investing cash flow-$818.00M-$5.51B
Financing cash flow-$3.62B$2.09B
Depreciation & amortization$2.46B$2.29B
Stock-based compensation$258.00M$247.00M
Dividends paid$1.20B$1.10B
Share buybacks$1.00B$500.00M

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.